Researchers developed a tool for predicting the prognosis of people with chronic lung disease-related pulmonary hypertension.
Pulmonary hypertension (PH) risk grows over time for patients with narrowing of the aorta, the body's biggest blood vessel, ...
Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).
Columnist Jen Cueva has gotten more adept at listening to her body and making adjustments to manage her PH and leave room for joy.
Boosting the production of a protein called myotubularin-related protein 7 (MTMR7) reversed signs of pulmonary arterial hypertension (PAH) in a mouse model of the disease, a study shows. MTMR7 ...